Guided Therapeutics Books Investment, Signs MOU with Potential China Distributor

Guided Therapeutics of the US booked $720,000 from a group of unidentified investors and signed an MOU to negotiate China distribution rights for a cervical cancer screening device, the LuViva ® Advanced Cervical Scan. The investment bought 4 million shares Guided Therapeutics stock and warrants for an additional 2 million shares. The shares are worth $560,000 at the current price. More details.... Stock Symbols: (OTCBB: GTHP) (OTCQB: GTHP) Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.